Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Sheng, Mina; b; 1 | Lu, Hanzhanga; c; 1 | Liu, Peiyinga; c | Li, Yanga; c | Ravi, Harshana; c | Peng, Shin-Leia; c; g | Diaz-Arrastia, Ramond | Devous, Michael D.e | Womack, Kyle B.e; f; *
Affiliations: [a] Advanced Imaging Research Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA | [b] Department of Radiology, Beijing Eden Hospital, Beijing, China | [c] Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA | [d] Department of Neurology, University of Pennsylvania Perelman School of Medicine, Penn Presbyterian Medical Center, Philadelphia, PA, USA | [e] Department of Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center, Dallas, TX, USA | [f] Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA | [g] Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, Taiwan
Correspondence: [*] Correspondence to: Kyle B. Womack, MD, Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9129, USA. Tel.: +1 214 648 0315; Fax: +1 214 648 2031; E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: Background:Alzheimer’s disease (AD) is the leading cause of degenerative dementia in the aging population. Patients with AD have alterations in cerebral hemodynamic function including reduced cerebral blood flow (CBF) and cerebral metabolic rate. Therefore, improved cerebrovascular function may be an attractive goal for pharmaceutical intervention in AD. Objective:We wished to observe the acute effects of sildenafil on cerebrovascular function and brain metabolism in patients with AD. Methods:We used several novel non-invasive MRI techniques to investigate the alterations of CBF, cerebral metabolic rate of oxygen (CMRO2), and cerebrovascular reactivity (CVR) after a single dose of sildenafil administration in order to assess its physiological effects in patients with AD. CBF, CMRO2, and CVR measurements using MRI were performed before and one hour after the oral administration of 50 mg sildenafil. Baseline Montreal Cognitive Assessment score was also obtained. Results:Complete CBF and CMRO2 data were obtained in twelve patients. Complete CVR data were obtained in eight patients. Global CBF and CMRO2 significantly increased (p = 0.03, p = 0.05, respectively) following sildenafil administration. Voxel-wise analyses of CBF maps showed that increased CBF was most pronounced in the bilateral medial temporal lobes. CVR significantly decreased after administration of sildenafil. Conclusion:Our data suggest that a single dose of sildenafil improves cerebral hemodynamic function and increases cerebral oxygen metabolism in patients with AD.
Keywords: Cerebral blood flow, cerebral metabolic rate of oxygen, cerebrovascular reactivity, magnetic resonance imaging, Montreal Cognitive Assessment, sildenafil
DOI: 10.3233/JAD-161006
Journal: Journal of Alzheimer's Disease, vol. 60, no. 4, pp. 1351-1364, 2017
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]